Seminar held on DPP-4 inhibitors and COVID-19 related outcomes among patients with T2D

A scientific seminar on "DPP-4 inhibitors and COVID-19 related outcomes among patients with type 2 diabetes (T2D)" was organised by NIPRO JMI Pharma Ltd. at the capital recently, says a press release. Distinguished Professor AK Azad Khan, President of Bangladesh Diabetic Association, was the chief guest at the event.

The session speaker, renowned endocrinologist Dr Md Feroz Amin presented that the use of DPP-4 inhibitors in COVID-19 patients with diabetes might significantly lower the probability of all-cause mortality and severe manifestations of COVID-19.